We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.5%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$3.04B
AUM Growth
–
Cap. Flow
+$3.06B
Cap. Flow
% of AUM
100.75%
Top 10 Holdings %
Top 10 Hldgs %
50.92%
Holding
50
New
50
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Crown Castle
CCI
|
+$160M |
| 2 |
Qualcomm
QCOM
|
+$158M |
| 3 |
Adobe
ADBE
|
+$157M |
| 4 |
Nike
NKE
|
+$155M |
| 5 |
Mondelez International
MDLZ
|
+$154M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Consumer Staples | 24.58% |
| 3 | Technology | 24.39% |
| 4 | Consumer Discretionary | 15.35% |
| 5 | Real Estate | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Adobe
ADBE
$93.5B
| $161M | 5.31% |
+3,543,222
| New | +$157M |
|
|
2
Nike
NKE
$66.1B
| $159M | 5.22% |
+4,984,698
| New | +$155M |
|
|
3
Crown Castle
CCI
$34.4B
| $158M | 5.18% |
+2,176,464
| New | +$160M |
|
|
JWN
4
DELISTED
Nordstrom
JWN
| $156M | 5.13% |
+2,604,333
| New | +$151M |
|
5
Johnson & Johnson
JNJ
$602B
| $154M | 5.06% |
+1,793,411
| New | +$152M |
|
6
Costco
COST
$419B
| $153M | 5.03% |
+1,384,179
| New | +$151M |
|
7
Target
TGT
$63.7B
| $152M | 5.01% |
+2,212,613
| New | +$154M |
|
8
Tapestry
TPR
$29.1B
| $152M | 5% |
+2,661,398
| New | +$150M |
|
|
9
Qualcomm
QCOM
$180B
| $152M | 4.99% |
+2,482,553
| New | +$158M |
|
|
ESRX
10
DELISTED
Express Scripts Holding Company
ESRX
| $151M | 4.97% |
+2,449,706
| New | +$148M |
|
|
WFM
11
DELISTED
Whole Foods Market Inc
WFM
| $151M | 4.97% |
+2,934,887
| New | +$142M |
|
12
Walt Disney
DIS
$173B
| $150M | 4.93% |
+2,375,746
| New | +$150M |
|
13
CVS Health
CVS
$136B
| $149M | 4.89% |
+2,599,685
| New | +$151M |
|
14
Estee Lauder
EL
$30B
| $146M | 4.8% |
+2,219,242
| New | +$151M |
|
|
EMC
15
DELISTED
EMC CORPORATION
EMC
| $146M | 4.79% |
+6,162,550
| New | +$145M |
|
|
16
Mondelez International
MDLZ
$78.8B
| $145M | 4.76% |
+5,076,617
| New | +$154M |
|
17
IBM
IBM
$206B
| $145M | 4.75% |
+791,170
| New | +$154M |
|
18
Oracle
ORCL
$358B
| $138M | 4.55% |
+4,500,164
| New | +$149M |
|
19
Biogen
BIIB
$30.8B
| $79.5M | 2.62% |
+369,444
| New | +$78.9M |
|
20
Gilead Sciences
GILD
$169B
| $76.9M | 2.53% |
+1,499,924
| New | +$78.2M |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $76.2M | 2.51% |
+1,302,374
| New | +$78.4M |
|
22
Amgen
AMGN
$201B
| $76M | 2.5% |
+770,388
| New | +$79.9M |
|
23
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $4.16M | 0.14% |
+94,004
| New | +$4.4M |
|
24
Vanguard Extended Market ETF
VXF
$30.5B
| $3.7M | 0.12% |
+52,920
| New | +$3.66M |
|
25
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
| $2.05M | 0.07% |
+37,455
| New | +$2.18M |
|
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for WestEnd Advisors, which disclosed 50 positions worth $3.04B. Its ten largest holdings account for 51% of the portfolio.
Its largest position is Crown Castle: 2,176,464 shares worth $158M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Consumer Staples and Technology.
- WestEnd Advisors's largest Q2 2013 buy was Crown Castle: 2,176,464 shares worth $158M.
- WestEnd Advisors's ten largest holdings make up 51% of its $3.04B portfolio in Q2 2013.
- WestEnd Advisors disclosed 50 positions in Q2 2013, its first 13F filing on record.
Based on WestEnd Advisors's 13F filing for Q2 2013, filed 22 Jul 2013.